Sodium tanshinone IIA sulfonate protects against hyperhomocysteine-induced vascular endothelial injury via activation of NNMT/SIRT1-mediated NRF2/HO-1 and AKT/MAPKs signaling in human umbilical vascular endothelial cells
Homocysteine (Hcy) is one of the independent risk factors of cardiovascular disease. Sodium tanshinone IIA sulfonate (STS) is a hydrophilic derivate of tanshinone IIA which is the main active constitute of Chinese Materia Medica Salviae Miltiorrhizae Radix et Rhizoma, and exhibits multiple pharmacol...
Main Authors: | Zhong-Yan Zhou, Wen-Ting Shi, Jing Zhang, Wai-Rong Zhao, Ying Xiao, Kai-Yu Zhang, Jie Ma, Jing-Yi Tang, Yu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222015268 |
Similar Items
-
Hyperhomocysteinemia: Focus on Endothelial Damage as a Cause of Erectile Dysfunction
by: Gianmaria Salvio, et al.
Published: (2021-01-01) -
Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis
by: Ekaterina Dubchenko, et al.
Published: (2020-09-01) -
The role of homocysteine in endothelial dysfunction
by: Elena Visternicean
Published: (2017-04-01) -
STUDYING DOSE-DEPENDENT ENDOTHELIO- AND CARDIOPROTECTIVE ACTIVITY OF SELECTIVE ARGINASE II INHIBITOR IN HYPERHOMOCYSTEINE-INDUCED ENDOTHELIAL DYSFUNCTION
by: Vladimir Yakushev, et al.
Published: (2016-03-01) -
Possible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment
by: Eun Seong Hwang, et al.
Published: (2020-04-01)